75 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
cybersecurity risk management, strategy, governance and incident reporting could be time-intensive and costly, resulting in a material adverse effect on our … of laws, regulations and investor-driven standards relating to corporate governance and other matters.
Laws and regulations affecting public companies
424B5
unpri 64e8
29 Nov 23
Prospectus supplement for primary offering
5:05pm
8-K
4w2lunoiz3gy fz2
8 Aug 23
Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover
4:07pm
424B5
yv3z806t3879 4bud05
23 Jun 22
Prospectus supplement for primary offering
4:09pm
424B5
bmyx d68mnonfkg3k
22 Jun 22
Prospectus supplement for primary offering
4:05pm
8-K
r31nmv5p0 st
10 Mar 22
Results of Operations and Financial Condition
4:09pm
424B5
ksxj42y
1 Mar 22
Prospectus supplement for primary offering
5:12pm